Blog | HemaCare

CD34+ Stem Cell Treatment Provides Hope for Patients with Refractory Angina

Jan 5, 2017 8:20:53 AM / by Stacy Matthews Branch, DVM, PhD posted in Angina, CD34, research, stem cell research, Stem Cell Therapy, stem cell treatment, stem cells

0 Comments

Patients with angina suffer with chronic, severe pain in the chest and other parts of the torso due to low blood supply to the heart muscle. Although there are standard treatments that work for many with angina, some have a more debilitating form that does not respond to treatment (refractory angina). About 1 million people in the U.S. have refractory angina. However, there is hope for those who are without viable treatment options. Researchers have observed that CD34+ stem cell treatment may help improve angina in patients who do not respond to other treatments.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts